Turning Point Therapeutics Inc (TPTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | TPTX | CPRX | NAMS | ||
| Company | Turning Point Therapeutics Inc | Catalyst Pharm Inc | Newamsterdam Pharma Company N.V. | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 75.99 | 31.44 | 31.56 | ||
| High | 76.01 | 31.44 | 33.41 | ||
| Low | 75.98 | 31.41 | 31.56 | ||
| Latest | 76.01 | 31.45 | 33.07 | ||
| Change | +0.52 | +0.03 | +1.34 | ||
| % Change | +0.69% | +0.10% | +4.22% | ||
| Volume | 2,843,300 | 754,647 | 1,039,950 | ||
| 20-Day Average Volume | 962,475 | 1,642,317 | 1,339,616 | ||
| Previous Close | 75.49 | 31.42 | 31.73 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 75.11 | 31.34 | 31.26 | ||
| 20-Day Raw Stochastic | 100.00% | 90.48% | 54.90% | ||
| 20-Day Relative Strength | 74.20 | 70.51 | 52.36 | ||
| Weighted Alpha | -18.70 | +54.29 | +29.28 | ||
| Today's Opinion | 96% Buy | 100% Buy | 56% Sell | ||
| Previous Opinion | 96% Buy | 100% Buy | 72% Sell | ||
| Last Month's Opinion | 88% Buy | 100% Buy | 72% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.29% since 08/09/22 | +0.13% since 06/18/26 | +10.58% since 06/18/26 | ||
| Low | 74.86 on 08/10/22 | 31.36 on 06/22/26 | 29.70 on 06/22/26 | ||
| High | 76.01 on 08/16/22 | 31.44 on 06/26/26 | 33.37 on 06/26/26 | ||
| 1-Month | |||||
| %Chg | +1.82% since 07/15/22 | +0.29% since 05/26/26 | -8.65% since 05/26/26 | ||
| Low | 74.57 on 07/21/22 | 31.23 on 05/29/26 | 29.09 on 06/16/26 | ||
| High | 76.01 on 08/16/22 | 31.44 on 06/26/26 | 37.34 on 05/27/26 | ||
| 3-Month | |||||
| %Chg | +134.02% since 05/16/22 | +29.57% since 03/26/26 | +5.55% since 03/26/26 | ||
| Low | 30.85 on 05/25/22 | 23.05 on 03/30/26 | 27.85 on 04/28/26 | ||
| High | 76.01 on 08/16/22 | 32.56 on 04/27/26 | 42.21 on 05/11/26 | ||
| 6-Month | |||||
| %Chg | +124.48% since 02/16/22 | +29.03% since 12/26/25 | -6.48% since 12/26/25 | ||
| Low | 23.77 on 03/15/22 | 22.13 on 01/13/26 | 27.85 on 04/28/26 | ||
| High | 76.01 on 08/16/22 | 32.56 on 04/27/26 | 42.21 on 05/11/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 3,806,125 | 3,846,436 | 3,709,364 | ||
| Shares Outstanding, K | 50,074 | 122,420 | 116,904 | ||
| Annual Sales | 30,830,000 | 588,990,000 | 22,500,000 | ||
| Annual Net Income | -236,550,000 | 214,330,000 | -203,820,000 | ||
| Last Quarter Sales | 120,000 | 149,390,000 | 3,040,000 | ||
| Last Quarter Net Income | -123,090,000 | 63,730,000 | -48,440,000 | ||
| 60-Month Beta | -0.18 | 0.74 | 0.07 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -2.48 on 08/08/22 | 0.79 on 05/11/26 | -0.40 on 05/07/26 | ||
| Earnings Date | 11/08/22 | 08/05/26 | 08/05/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 11.90 | 0.00 | ||